Source link : https://san-francisco-news.com/2025/10/06/merck-invests-nearly-2-billion-in-breakthrough-oral-lipid-lowering-drug-from-chinese-biotech/
Merck pledges nearly $2 billion to acquire an oral lipid-lowering drug from a Chinese biotech, aiming to expand its cardiovascular portfolio and address global cholesterol management needs.
—-
Author : Ethan Riley
Publish date : 2025-10-06 04:30:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
Categories